Targeting transforming growth factor-β signaling in liver metastasis of colon cancer

This publication has 13 references indexed in Scilit:

• LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
  Molecular Cancer Therapeutics, 2008
• Blocking transforming growth factor–beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
  Hepatology, 2008
• Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness
  Molecular Pharmacology, 2007
• Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor KinaseIn vivo
  Clinical Cancer Research, 2006
• TGFβ: the molecular Jekyll and Hyde of cancer
  Nature Reviews Cancer, 2006
• Non-Smad TGF-β signals
  Journal of Cell Science, 2005
• Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis
  Experimental Cell Research, 2005
• Development of TGF-β signalling inhibitors for cancer therapy
  Nature Reviews Drug Discovery, 2004
• Smad-dependent and Smad-independent pathways in TGF-β family signalling
  Nature, 2003
• Consequences of altered TGF-β expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects
  Oncogene, 2002